Ethnic differences in renal handling of water and solutes in hypertension

Hypertension

Volumn 52, Issue 2, 2008, Pages 203-204

  Burnier, Michel ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMILORIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM; CALCIUM ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; CHLORIDE CHANNEL; DIURETIC AGENT; FUROSEMIDE; LOOP DIURETIC AGENT; POTASSIUM; POTASSIUM CHANNEL; SODIUM; SODIUM CHANNEL; UNCLASSIFIED DRUG; VASOPRESSIN; VASOPRESSIN RECEPTOR ANTAGONIST; VASOPRESSIN V1 RECEPTOR ANTAGONIST; VASOPRESSIN V2 RECEPTOR ANTAGONIST; WATER;

DRUG EFFECT; EDITORIAL; ESSENTIAL HYPERTENSION; ETHNIC DIFFERENCE; FLUID INTAKE; HUMAN; KIDNEY TUBULE ABSORPTION; LOW DRUG DOSE; NEPHRON; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RENOVASCULAR HYPERTENSION; RISK FACTOR; SODIUM ABSORPTION; SODIUM EXCRETION; TREATMENT RESPONSE; URINARY EXCRETION; VASOPRESSIN BLOOD LEVEL; WATER RETENTION; CAUCASIAN; COMPARATIVE STUDY; ETHNOLOGY; FEMALE; HOSPITALIZATION; HYPERTENSION; KIDNEY FUNCTION TEST; MALE; METABOLIC DISORDER; METABOLISM; NEGRO; NOTE; PATHOPHYSIOLOGY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STATISTICS;

AFRICAN CONTINENTAL ANCESTRY GROUP; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; HYPERTENSION; KIDNEY FUNCTION TESTS; MALE; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SODIUM; WATER; WATER-ELECTROLYTE IMBALANCE;

EID: 49849087580     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.108.115592     Document Type: Editorial

References (11)

1. Weinberger MH, Miller JZ, Luft FC, Grim CE, Fineberg NS. Definitions and characteristics of sodium sensitivity and blood pressure resistance. Hypertension. 1986;8(suppl II):II-127-II-134.
2. Luft FC, Miller JZ, Grim CE, Fineberg NS, Christian JC, Daugherty SA, Weinberger MH. Salt sensitivity and resistance of Mood pressure. Age and race as factors in physiological response. Hypertension. 1991;17:1102-1108.
3. Weder AB. Red-cell lithium-sodium countertransport and renal lithium clearance in hypertension. N Engl J Med. 1986;314:198-201.
4. Lifton RP, Gharavi AG, Geller DS. Molecular mechanisms of human hypertension. Cell. 2001;23:545-555.
5. Chiolero A, Maillard M, Nussberger J, Brunner HR, Burnier M. Proximal sodium reabsorption: an independent determinant of blood pressure response to salt. Hypertension. 2000;36:631-637.
6. Burnier M, Bochud M, Maillard M. Proximal tubular function and salt sensitivity. Curr Hypertens Rep. 2006;8:8-15.
7. Pratt JH, Ambrosius WT, Agarwal R, Eckert GJ, Newman S Racial difference in the activity of the amiloride-sensitive epithelial sodium channel. Hypertension. 2002;40:903-908.
8. Chun T-Y, Bankir L, Eckert GJ, Bichet DG, Saha C, Zaidi S-A, Wagner MA, Pratt JH. Ethnic differences in renal responses to furosemide. Hypertension. 2008;52:241-248.
9. Matterson BJ, Reda DJ, Cushrnan WC, Massie BM, Preis ED, Kochar MS, Hamburger RJ, Fye C, Lakshman R, Gottdiener J, Ramirez EA, Henderson WG, for the Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Single-drug therapy for hypertension in men. N Engl J Med. 1993;328:914-921.
10. Weir MR, Chrysant SG, McCarron DA, Canossa-Terris M, Cohen JD, Gunter PA, Lewin AJ, Mennella RF, Kirkegaard LW, Hamilton JH, Weinberger MH, Weder AB. Influence of race and dietary salt on the antihypertensive efficacy of an angiotensin-converting enzyme inhibitor or a calcium channel antagonist in salt-sensitive hypertensives. Hypertension. 1998;31:1088-1096.
11. Bankir L, Perucca J, Weinberger MH. Ethnic differences in urine concentration: possible relationship to blood pressure. Clin J Am Soc Nephrol. 2007;2:304-312.